CPS Non-Muscle Invasive Bladder Cancer (2016)

Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Problem Solving (CPS) Protocols guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This guideline provides a risk-stratified clinical framework for the management of NMIBC.

Target Audience

  • Urologists (Practicing; Recertification Candidates; International)
  • Residents

Learning Objectives

After completion of this activity, participants will be able to:

  1. Interpret and explain the appropriate diagnosis, prevention and treatment of the related guideline.
  2. Perform appropriate methods of evaluation and management according to the guideline.
  3. Analyze the risks and benefits for treatment according to the guideline.
  4. Integrate AUA guidelines into clinical practice.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
Course expires: 


  • William Huang, MD
  • Nicholas Donin, MD


  • Sam Chang, MD
  • Chad Ritch, MD

Faculty Disclosures

Sam S. Chang, MDJanssenSelfConsultant or AdvisorYes
 GLGSelfConsultant or AdvisorYes
 BayerSelfConsultant or AdvisorYes
 astellasSelfConsultant or AdvisorYes
 NIHSelfScientific Study or TrialYes
Nicholas Donin, MDNothing to disclose
William C. Huang, MDPhotocureSelfScientific Study or TrialYes
Chad R. Ritch, MDNothing to disclose

Education Council

Timothy Charles Brand, MD Nothing to disclose
Peter Robert Carroll, MD, MPHNIHScientific Study or TrialYes
 Department of DefenseScientific Study or TrialYes
 Myriad GeneticsScientific Study or TrialNo
 AUA UpdateLeadership PositionYes
 Genomic HealthScientific Study or TrialNo
Sam S. Chang, MDastellasConsultant or AdvisorYes
 NIHScientific Study or TrialYes
 GLGConsultant or AdvisorYes
 BayerConsultant or AdvisorYes
 JanssenConsultant or AdvisorYes
Jody Donaldson   
Shelby Englert   
Matthew Thomas Gettman, MD   
Inderbir Singh Gill ,MD, M.Ch.EDAPConsultant or AdvisorYes
William C. Hulbert Jr. MD  
Douglas A. Husmann MD  
Brant Inman, MD, MS, FRCSCDendreonScientific Study or TrialNo
 Abbott LaboratoriesScientific Study or TrialNo
 Genentech IncScientific Study or TrialNo
 Combat MedicalConsultant or AdvisorYes
 FKD TherapiesScientific Study or TrialNo
 AstraZenecaConsultant or AdvisorYes
 Taris BiomedicalConsultant or AdvisorYes
Mark L. Jordan MD,FACS  
Hari K. Koul, MSC,PHDNovartis PharmaceuticalsConsultant or AdvisorYes
 Urologic ResearchLeadership PositionNo
 PLOS oneLeadership PositionNo
 OMICS groupLeadership PositionNo
 Open Access PublishingLeadership Position, Health PublishingYes
Martin A. Koyle MD  
John Stephen Lam MD  
Gary Evan Lemack ,MDAstellasConsultant or Advisor, Meeting Participant or LecturerYes
 AllerganConsultant or Advisor, Meeting Participant or LecturerYes
 SophirisScientific Study or TrialYes
 MedtronicConsultant or AdvisorYes
Yair Lotan ,MDabbottScientific Study or TrialNo
 DanoneConsultant or Advisor, Scientific Study or TrialYes
 CepheidScientific Study or TrialNo
 Pacific EdgeScientific Study or TrialNo
 FKDScientific Study or TrialNo
 MDxHealthConsultant or AdvisorYes
 biocancellScientific Study or TrialNo
 Genomic HealthScientific Study or TrialNo
 GenomeDx Biosciences IncScientific Study or TrialNo
 photocureScientific Study or TrialNo
Manoj Monga, MDFortecOtherYes
 endourology societyLeadership PositionNo
Victor William Nitti MDAstellasHealth Publishing, Scientific Study or TrialNo
 AllerganHealth Publishing, Scientific Study or TrialNo
 Serenity PharmeuticalsInvestment InterestYes
 Cook MyositeScientific Study or TrialNo
Christopher Porter, MD  
Gail S. Prins PhD  
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
Lee Richstone, MD  
Heather Schultz, NPSUNAMeeting Participant or LecturerYes
Karl-Dietrich Sievert ,MD, PhDAMSMeeting Participant or LecturerYes
 MedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes
 AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 NeotractMeeting Participant or LecturerYes
Joseph A. Smith Jr.,MD  
Edouard John Trabulsi, MDGenomeDxConsultant or AdvisorYes


Method of Participation
Learners will participate in this interactive online educational activity by completing a pre-test, reading the AUA Guideline, complete the slides and case studies, answering multiple choice questions, examining patient tools and resources and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete each activity: 2.0 hours

Release Date: December, 2016
Expiration Date: December, 2019

AUA Disclosure Policy
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
·         Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup
·         Limit content to evidence with no recommendations
·         Introduction of a debate format with an unbiased moderator (point-counterpoint)
·         Inclusion of moderated panel discussion
·         Publication of a parallel or rebuttal article for an article that is felt to be biased
·         Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
·         Divestiture of the relationship by faculty

Accreditation Statement
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American Urological Association designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Evidence-Based Content
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

AUA Privacy and Confidentiality Policy

Contact Information
American Urological Association
Office of Education
1000 Corporate Blvd
Linthicum, MD 21090
Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282)
Phone: 410-689-3700
Fax: 410-689-3800

CME Information
For all inquiries regarding CME credit email: cme@AUAnet.org

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Please login or register to take this course.